<!-- EVIDENCE_GRADE_WARN: This draft is limited to lifecycle-governance concepts from staged source material. It does not provide deployment-specific proof, outcome data, or named case examples showing a healthcare organization successfully paused, rolled back, retired, replaced, or exited an AI workflow. -->

# Healthcare AI Needs an Exit Plan

Launch controls are only one part of healthcare AI governance. After an organization sets a baseline, defines monitoring expectations, and assigns accountability, it still needs a practical answer to a harder question: what happens when evidence changes, workflow fit deteriorates, vendor support shifts, or user concerns continue to surface? In governance terms, the missing piece is an exit plan.

That does not mean every healthcare AI tool is destined to fail, or that the sector has already developed strong retirement discipline. It means lifecycle governance is incomplete if it can approve a tool for use but cannot specify the conditions and actions for limiting, pausing, rolling back, retiring, or replacing that workflow later.

## Exit controls make monitoring operational

Monitoring matters only when signals connect to named actions. A healthcare AI program can collect review metrics, user concerns, change notices, and workflow feedback, but those inputs have limited operational value unless the organization has already decided which findings trigger narrower use, pause, rollback, retirement review, or replacement review.

That is a governance claim, not deployment proof. The staged material supports the need for off-ramp criteria, but it does not show that any specific organization has reached a threshold for pause or rollback, and it does not show that taking one of those actions would improve outcomes.

The off-ramp set is broader than a single emergency stop:

- `Limit` means narrowing scope, users, settings, or decision weight while questions are reviewed.
- `Pause` means stopping use until unresolved concerns, missing evidence, unstable inputs, or unreviewed changes are addressed.
- `Rollback` means restoring a prior workflow or prior tool state through an authorized path.
- `Retire` means ending use as a normal lifecycle decision when the workflow is no longer fit for purpose.
- `Replace` means introducing a successor workflow or tool, with its own baseline and review burden rather than an assumed automatic upgrade.

Each action needs criteria, ownership, and a documented path back to a known workflow state. Without that structure, monitoring can generate alerts without producing accountable decisions.

## Portfolio records turn off-ramps into real responsibilities

An organization cannot limit, pause, retire, or replace what it cannot identify. Exit controls therefore depend on a portfolio inventory that records which AI-mediated workflows are active, limited, suspended, retired, or experimental, along with intended use, evidence status, monitoring status, and review cadence.

Just as important, the inventory has to connect to named owners. Someone must be responsible for evidence review, monitoring follow-up, change approval, user communication, and transition decisions. Otherwise, the off-ramp exists only as policy language, with no accountable decision-maker attached.

This remains governance guidance, not proof of mature execution. A documented inventory does not demonstrate that the inventory is complete, current, or effective in practice. It does, however, define the minimum structure needed to reduce the risk of hidden pilots, unmanaged tools, or workflows that remain active after their evidence base or operating context has changed.

## Retirement and replacement need evidence, not assumption

<!-- EVIDENCE_GRADE_WARN: The staged material supports lifecycle framing, but it does not provide named examples of a healthcare organization retiring or replacing a specific AI tool, nor does it prove that any replacement improved performance, safety, trust, or outcomes. -->

Retirement should be treated as a normal lifecycle outcome, not as an admission that AI was a mistake. Healthcare workflows change. Patient populations change. Data inputs change. Vendor support models change. Organizational priorities change. A tool can become misaligned with its setting without meaning the original decision was irrational, or that any replacement is automatically better.

That distinction matters because replacement is often framed too casually. A successor system is not a free governance pass. If a tool is replaced, the new tool still needs its own baseline, validation approach, workflow-fit review, and monitoring plan. Replacement changes the object under governance; it does not remove the need for governance.

The defensible claim is narrower: retirement and replacement decisions should be documented with evidence, rationale, fallback or successor workflow details, and communication plans.

## Resilience includes vendor exit and transition communication

Exit planning is not only about model behavior. In healthcare operations, AI-mediated workflows can depend on hosted services, data feeds, documentation, support teams, update channels, audit access, and contract terms. A model may remain unchanged while surrounding service conditions still shift enough to require review or transition planning.

That is why vendor exit belongs inside governance and resilience planning. An organization should know which functions depend on the vendor, what data return or deletion obligations exist, what logs and records must remain available, how support handoff would work, and what replacement or fallback workflow applies if service conditions change.

The communication side matters just as much. If a workflow is limited, paused, retired, or replaced, affected users need more than a governance label. They need to know what changed, who is affected, what workflow applies now, and where to raise concerns. In some contexts, patient-facing communication may also matter when the workflow meaningfully affects care, access, or data use.

Again, the claim here is about accountable process, not measured results. The staged material supports communication as part of lifecycle management, but it does not show that a notice was understood, that a fallback workflow performed well, or that any transition improved safety, trust, or outcomes.

## The operating question after launch

The next governance test for healthcare AI is not simply whether organizations can approve tools for use. It is whether they can define the conditions for limiting them, pausing them, rolling them back, retiring them, or replacing them without confusion about ownership, fallback workflows, vendor dependencies, or user communication.

That is the practical value of exit controls: they turn monitoring and accountability into decisions that can actually be executed. But the evidence boundary should remain explicit. The staged material supports lifecycle-governance concepts only. It does not provide deployment-specific evidence, outcome data, or named case examples proving that healthcare organizations have already executed these off-ramps successfully.
